(Exact name of small business issuer as specified in its charter)
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
(Address of principal executive offices)
(Registrant's Telephone number)
(Former Name or Former Address, if Changed Since Last Report)
On June 28, 2011, Echo Therapeutics, Inc. (the "Company") issued a press release (the "Press Release") announcing that its common stock has been cleared for listing on NASDAQ. The Company's common stock, which previously traded on the OTC Bulletin Board, began trading on NASDAQ on June 29, 2011. The Company's ticker symbol will remain "ECTE". A copy of the complete text of the Company's June 28, 2011, press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The Exhibits listed in the Exhibit Index immediately preceding such Exhibits are filed with or incorporated by reference in this report.
Echo Therapeutics, Inc. |
By: | /s/ Patrick T. Mooney |
Name: Patrick T. Mooney | |
Title: CEO and President |
Exhibit No. | Description | |
EX-99.1 | Press release issued by the Company on June 28, 2011. |